Acculink
Device Vascular
PDI 08717648076398
General payments
$134,648
Research payments
$925,000
Through program year 2025, $134,648 in general payments and $925,000 in research payments were reported against Acculink (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $18,279 | 34 |
| 2024 | General | $32,651 | 117 |
| 2024 | Research | $450,000 | 3 |
| 2023 | General | $38,231 | 112 |
| 2023 | Research | $475,000 | 4 |
| 2022 | General | $45,487 | 72 |
Breakdown
The top 5 of 16 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
335 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.